Shu Ding
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Dermatology top 5%
- Skin Protection and Aging
Papers in
- Immunology 10
- Immune Cell Function and Interaction 5
- T-cell and B-cell Immunology 3
- Co-authors
- Qianjin Lu (5 shared papers)Jianyun Lu (15 shared papers)Ming Zhao (3 shared papers)Hai Long (3 shared papers)Qinghai Zeng (8 shared papers)Gongping Liang (2 shared papers)Lihua Gao (10 shared papers)Jing Chen (6 shared papers)
- Journals
- Frontiers in Immunology (3 papers)Clinical Epigenetics (2 papers)Cellular and Molecular Immunology (2 papers)Photodiagnosis and Photodynamic Therapy (1 paper)International Immunopharmacology (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Shu Ding
28 papers receiving 655 citations
Peers
Comparison fields: 5 of 80
- Cancer Research 187
- Dermatology 94
- Immunology 179
- Rheumatology 84
- Complementary and Manual Therapy 9
Countries citing papers authored by Shu Ding
This map shows the geographic impact of Shu Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Ding more than expected).
Fields of papers citing papers by Shu Ding
This network shows the impact of papers produced by Shu Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Ding. The network helps show where Shu Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Shu Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 170 | |
| 2 | 2011 | 73 | |
| 3 | 2018 | 55 | |
| 4 | 2016 | 53 | |
| 5 | 2020 | 50 | |
| 6 | 2017 | 41 | |
| 7 | 2019 | 33 | |
| 8 | 2019 | 29 | |
| 9 | 2017 | 22 | |
| 10 | 2016 | 20 | |
| 11 | 2017 | 17 | |
| 12 | 2020 | 17 | |
| 13 | 2021 | 13 | |
| 14 | Ozonated autohemotherapy elevates PPAR-γ expression in CD4+ T cells and serum HDL-C levels, a potential immunomodulatory mechanism for treatment of psoriasis. | 2021 | 12 |
| 15 | 2017 | 12 | |
| 16 | 2024 | 11 | |
| 17 | 2021 | 6 | |
| 18 | 2017 | 5 | |
| 19 | 2020 | 5 | |
| 20 | 2023 | 4 |
About Shu Ding
Shu Ding is a scholar working on Immunology, Molecular Biology, Oncology, Dermatology and Rheumatology, having authored 29 papers that have together received 667 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (5 papers), Cytokine Signaling Pathways and Interactions (4 papers), T-cell and B-cell Immunology (3 papers), Cutaneous Melanoma Detection and Management (2 papers), Dermatologic Treatments and Research (2 papers), Skin Protection and Aging (2 papers), Systemic Lupus Erythematosus Research (2 papers) and Sympathectomy and Hyperhidrosis Treatments (2 papers). The work is most often cited by research in Cancer Research (187 citations), Dermatology (94 citations), Immunology (179 citations), Rheumatology (84 citations) and Complementary and Manual Therapy (9 citations). Shu Ding has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Qianjin Lu, Jianyun Lu, Ming Zhao, Hai Long, Qinghai Zeng, Gongping Liang, Lihua Gao, Jing Chen, Jinhua Huang and Sha Zhao. Their work appears in journals such as Frontiers in Immunology, Clinical Epigenetics, Cellular and Molecular Immunology, Photodiagnosis and Photodynamic Therapy and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.